SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (369)11/29/1999 8:10:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1169
 
listened to the conference call..... just an incredible little deal, reflecting the sort of leverage that the company now has.... do enough deals like this, and you turn around someday and find that your company is worth beaucoup bucks.......

"Supply royalty" of 20-30%

multiple ops, additional deals in this area

Taisho pays for 100% of any Japan-specific development costs

2nd generation ICE inhibitors, going well